CRISPR Therapeutics AG (CRSP)
49.45
-2.03
(-3.94%)
USD |
NASDAQ |
Jun 10, 16:00
49.40
-0.05
(-0.10%)
After-Hours: 16:47
CRISPR Therapeutics EBITDA (TTM)
EBITDA (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBITDA (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -- |
| December 31, 2025 | -- |
| September 30, 2025 | -- |
| June 30, 2025 | -- |
| March 31, 2025 | -- |
| December 31, 2024 | -- |
| September 30, 2024 | -- |
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| Date | Value |
|---|---|
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
EBITDA Definition
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.
EBITDA (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median